Add BrightSurf on Google Email

New video test for Parkinson’s uses AI to track how the disease is progressing

A new video-processing technique developed at the University of Florida uses artificial intelligence to track Parkinson's disease progression in patients, allowing neurologists to better monitor their condition and quality of life. The system analyzes video recordings of patients performing the finger-tapping test, a standard test for ...

SourceUniversity of Florida·JournalIEEE Transactions on Neural Networks·DateJul 23, 2024

Researchers create new template of the human brain

Researchers created a new cortical surface template called 'OpenNeuro Average' that provides greater accuracy and efficiency in analyzing neuroimaging data. The template is based on the geometric shape of the brain and can be used for studies on cognition, clinical neuroscience, autism, and neurodegenerative diseases.

SourceDartmouth College·JournalNature Methods·TypeComputational simulation/modeling·DateJul 16, 2024

Protein droplets likely don’t cause Parkinson’s

Researchers investigated the relationship between protein aggregation and liquid-liquid phase separation, finding that droplet formation may actually protect against aggregation. The study, led by Paul Scherrer Institute, used over 500 conditions to test the behavior of alpha-synuclein proteins.

SourcePaul Scherrer Institute·JournalAdvanced Science·TypeExperimental study·DateJul 15, 2024

Major trial looks at most effective speech therapy for people with Parkinson’s disease

A major clinical trial led by the University of Nottingham found that LSVT LOUD was more effective at reducing the impact of voice problems in people with Parkinson's disease compared to no speech and language therapy or NHS delivered therapy. The treatment improved communication skills, enabling participants to go out and socialize wi...

SourceUniversity of Nottingham·JournalThe BMJ·TypeRandomized controlled/clinical trial·DateJul 10, 2024

Risk of Parkinson’s more than double for people with anxiety

A new study by UCL researchers found that people with anxiety over the age of 50 are at least twice as likely to develop Parkinson's disease. The study, published in the British Journal of General Practice, also identified symptoms such as depression, sleep disturbance, and fatigue as risk factors for developing the condition.

SourceUniversity College London·JournalBritish Journal of General Practice·TypeObservational study·DateJun 24, 2024

Blood test could predict Parkinson’s seven years before symptoms

A team of researchers has developed a simple blood test that uses artificial intelligence (AI) to predict Parkinson's disease up to seven years before the onset of symptoms. The test analyzes a panel of eight blood-based biomarkers with concentrations altered in patients with Parkinson's, providing a diagnosis with 100% accuracy.

SourceUniversity College London·JournalNature Communications·TypeExperimental study·DateJun 18, 2024

Dopamine linked to mentalising abilities

Researchers at the University of Birmingham discovered a link between dopamine and mentalising abilities in healthy individuals. They found that altering dopamine levels affected participants' ability to accurately attribute mental states, with implications for treating conditions like Parkinson's disease.

SourceUniversity of Birmingham·JournalPLOS Biology·TypeExperimental study·DateJun 13, 2024

The newly elucidated pathophysiological progression of Parkinson’s disease from examinations of the major salivary glands and the heart

Patients with Parkinson's disease exhibiting sympathetic denervation in major salivary glands and the heart tend to have more advanced non-motor symptoms as they age. Autonomic nerve dysfunction may progress independently of nigrostriatal dopaminergic degeneration, suggesting a potential contribution of age to PD progression.

SourceToho University·JournalJournal of the Neurological Sciences·TypeObservational study·DateMay 30, 2024

Mount Sinai study identifies genetic link between inflammatory bowel disease and Parkinson’s disease

Researchers at Mount Sinai identified genetic connections between inflammatory bowel disease (IBD) and Parkinson’s disease (PD), highlighting potential for joint therapeutic strategies. The study found mutations in the LRRK2 gene as a common element linking both conditions, with implications for innovative treatments.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalGenome Medicine·TypeData/statistical analysis·DateMay 13, 2024

Therapeutic target identified to neutralise toxic forms of Parkinson's-associated protein

A region in alpha-synuclein protein aggregates has been identified as a potential therapeutic target to prevent conversion into toxic amyloid fibrils, which accumulate in the brains of people suffering from Parkinson's disease. The discovery opens the door to developing new therapeutic strategies for inactivating these toxic forms.

SourceUniversitat Autonoma de Barcelona·JournalJournal of the American Chemical Society·TypeExperimental study·DateMay 6, 2024

Genetic variations may predispose people to Parkinson’s disease following long-term pesticide exposure, study finds

A new study found that genetic variants in lysosomal genes may contribute to the development of Parkinson's disease in individuals exposed to high levels of pesticides. The research suggests a potential gene-environment interaction, where minor changes in these genes can lead to increased disease risk under stress.

SourceUniversity of California - Los Angeles Health Sciences·Journalnpj Parkinson s Disease·TypeRandomized controlled/clinical trial·DateApr 25, 2024

Protecting brain cells with cannabinol

Scientists at Salk Institute explore the clinical potential of cannabinol (CBN) in treating traumatic brain injury, Alzheimer's disease, and Parkinson's disease. They identify four CBN analogs with improved neuroprotective ability and drug-like efficacy.

SourceSalk Institute·JournalRedox Biology·DateApr 17, 2024

Scientists identify cell vulnerability ‘fingerprint’ related to Parkinson’s, Lewy body dementia

Researchers at Van Andel Institute have identified a gene expression pattern, akin to a disease-related fingerprint, in brain cells with Lewy bodies. This finding sheds light on the molecular changes that occur in these cells, which are key pathological hallmarks of Parkinson's disease and some dementias.

SourceVan Andel Research Institute·JournalNature Communications·TypeExperimental study·DateApr 16, 2024

HKU biologists discover propionate supplementation as a potential treatment for Parkinson's disease

Research finds that supplementing propionate suppresses neurodegeneration in animal models of Parkinson's disease by regulating interorgan signalling. Increasing propionate levels rescues transcriptional aberration and enhances energy production, promoting neuronal health without protein aggregate dispersal.

SourceThe University of Hong Kong·JournalCell Reports·TypeExperimental study·DateMar 21, 2024

New technique for Parkinson’s stem cell brain repair brings promise for patients

Researchers at the University of Galway have developed a new method for improving stem cell-based brain repair therapy for Parkinson's disease, which shows promising results in enhancing survival and maturation of cells in the brain. The technique uses a collagen hydrogel to support and protect the cells after transplantation.

SourceUniversity of Galway·JournalJournal of Neural Engineering·TypeRandomized controlled/clinical trial·DateMar 19, 2024

UC study: Subcutaneous infusion pump safe, effective for Parkinson’s treatment

A phase 3 trial co-led by a University of Cincinnati researcher found that subcutaneous levodopa delivery through an infusion pump is safe and effective in reducing symptoms for longer periods. The study resulted in almost two hours of additional 'on time' compared to traditional oral medication, paving the way for potential FDA approval.

SourceUniversity of Cincinnati·JournalThe Lancet Neurology·TypeRandomized controlled/clinical trial·DateMar 15, 2024

Modulation of cellular recycling by calcium ion dynamics across cellular compartments

Researchers discovered rapid calcium influx into mitochondria upon autophagy induction, coinciding with fluctuations in ER membrane calcium concentrations. Mitochondrial calcium transport may regulate mitophagy velocity, shedding light on disease mechanisms and potential therapeutic avenues for Parkinson's disease.

SourceKeAi Communications Co., Ltd.·JournalMitochondrial Communications·TypeExperimental study·DateMar 3, 2024